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In contrast to the class I phosphoinositide 3-kinases
(PI3Ks), the organismal roles of the kinase activity of
the class II PI3Ks are less clear. Here, we report
that class II PI3K-C2b kinase-dead mice are viable
and healthy but display an unanticipated enhanced
insulin sensitivity and glucose tolerance, as well
as protection against high-fat-diet-induced liver
steatosis. Despite having a broad tissue distribution,
systemic PI3K-C2b inhibition selectively enhances
insulin signaling only in metabolic tissues. In a pri-
mary hepatocyte model, basal PI3P lipid levels are
reduced by 60% upon PI3K-C2b inhibition. This
results in an expansion of the very early APPL1-pos-
itive endosomal compartment and altered insulin
receptor trafficking, correlating with an amplification
of insulin-induced, class I PI3K-dependent Akt sig-
naling, without impacting MAPK activity. These
data reveal PI3K-C2b as a critical regulator of endo-
somal trafficking, specifically in insulin signaling, and
identify PI3K-C2b as a potential drug target for insu-
lin sensitization.
INTRODUCTION
PI3Ks, a family of lipid kinases that are activated by growth
factors, hormones, and cytokines play key roles in cell
growth, proliferation, and differentiation (Jean and Kiger,
2014; Vanhaesebroeck et al., 2010). Mammals have eight iso-
forms of PI3K, divided into three classes of which the class I
PI3Ks have been most extensively studied. Through their
non-redundant roles in plasma membrane receptor signaling,
these PI3Ks have been implicated in overgrowth, cancer,
metabolic disease, and inflammation (Jean and Kiger, 2014;
Vanhaesebroeck et al., 2010). Class I PI3Ks convert the phos-Cell Rephatidylinositol(4,5)bisphosphate [PI(4,5)P2] lipid at the plasma
membrane to PI(3,4,5)P3, also known as PIP3. PIP3 and its
metabolite PI(3,4)P2 bind and modulate the activity of pleck-
strin homology (PH) domain-containing effectors such as
protein kinases (including Akt and Btk), adaptor proteins, and
regulators of small GTPases. Among the four class I PI3Ks iso-
forms (p110a, b, g, and d), p110a has been identified as the
most important isoform in systemic or hepatic insulin signaling
(Foukas et al., 2006; Knight et al., 2006; Sopasakis et al., 2010),
although within the hypothalamus both p110a and p110b are
required for normal energy homeostasis (Al-Qassab et al.,
2009; Tups et al., 2010).
The class II (PI3K-C2a, -C2b, and -C2g) and III (vps34) PI3K
isoforms are thought to mainly convert PI to PI3P on endosomal
and autophagic membranes, resulting in the recruitment and
activation of effector proteins containing FYVE or PX lipid-bind-
ing domains. Class II PI3Ks might also convert PI(4)P to PI(3,4)P2
(Nigorikawa et al., 2014; Posor et al., 2013). Class II PI3Ks have
been reported to be activated by a wide range of agonists, such
as growth factors, G protein-coupled receptors, and adhesion
molecules (reviewed in Falasca and Maffucci, 2012; Jean and
Kiger, 2014; Vanhaesebroeck et al., 2010). However, the molec-
ular details of how class II PI3Ks couple to this multitude of up-
stream receptors remain unclear.
Previous cell-based studies have implicated a role for class II
PI3Ks in the regulation of a broad variety of biological activities,
including glucose transport, neurosecretory granule release, in-
sulin secretion, endocytosis and muscle cell contraction (PI3K-
C2a), cell migration and K+ channel activation (PI3K-C2b), and
cell growth and survival (PI3K-C2a and PI3K-C2b) (Falasca and
Maffucci, 2012; Jean and Kiger, 2014). The organismal roles of
the class II/III PI3Ks remain less clear, with homozygous deletion
of PI3K-C2a or vps34 being embryonic lethal (Franco et al.,
2014; Yoshioka et al., 2012; Zhou et al., 2011) andmice homozy-
gous deletion of PI3K-C2b being viable without reported pheno-
types (Harada et al., 2005). PI3K-C2a gene knockout (KO)
studies have implicated this PI3K isoform in angiogenesis (Yosh-
ioka et al., 2012) and in the generation of the primary ciliumports 13, 1881–1894, December 1, 2015 ª2015 The Authors 1881
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Figure 1. Generation and Characterization of PI3K-C2bD1212A KI Mice
(A) Expression of PI3K-C2b protein in mouse tissues. Brain lysates from PI3K-C2b KOmice (Harada et al., 2005) were included as controls. 100 mg of protein was
loaded per lane.
(B) Gene targeting strategy to generate the constitutive D1212A knockin mutation in the Pik3c2b gene. The D1212A mutation was introduced in the DFGmotif in
exon 24 of the Pik3c2b gene. The FRT-flanked cassette encoding Pgk Neo selection marker was removed in vivo by breeding onto ACTB-Flp mice.
(legend continued on next page)
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(Franco et al., 2014). Mice homozygous for a gene-trap PI3K-
C2a allele, which encodes a PI3K-C2a protein with reduced ac-
tivity, are viable but develop chronic renal failure (Harris et al.,
2011).
All class II/III PI3K mutant mice reported to date were created
by gene targeting approaches that remove the protein of inter-
est but do not allow the discrimination between scaffold- and ki-
nase-dependent functions of these enzymes (Vanhaesebroeck
et al., 2005). In the present study, we have therefore generated
mice in which endogenous PI3K-C2b is converted to a kinase-
dead protein, thereby mimicking the impact of systemically
administered small molecule kinase inhibitors of PI3K-C2b.
Given previous evidence from cell-based studies that class II
PI3K is involved in insulin action, as shown for PI3K-C2a (Brown
et al., 1999; Dominguez et al., 2011; Falasca et al., 2007; Lei-
biger et al., 2010; Soos et al., 2001; Ursø et al., 1999), we
focused our initial characterization of the PI3K-C2b kinase-
dead mice on systemic glucose homeostasis. Our data reveal
a role for PI3K-C2b in the control of insulin receptor trafficking
and glucose metabolism in metabolic tissues and identify
this kinase as a component in the regulation of insulin signal
transduction.
RESULTS
Generation of PI3K-C2b Kinase-Dead Knockin Mice
There are currently no published data available on the tissue
distribution of the PI3K-C2b protein in mice. As shown in Fig-
ure 1A, PI3K-C2b protein expression was broad and varied
widely across different mouse tissues, in line with PI3K-C2b
mRNA profiling studies in human tissues (Ho et al., 1997 in
which PI3K-C2b is referred to as T105). Tissue distribution did
therefore not provide any clear indication for a possible in vivo
role of PI3K-C2b.
In order to assess the organismal role of the kinase activity of
PI3K-C2b, we generated a germline knockin (KI) mouse line in
which the genomic DNA encoding the aspartic acid residue on
position 1212 (D1212) in the conserved ATP-binding DFG motif
of PI3K-C2b was mutated to alanine (further referred to as
D1212A; Figure 1B). This gene targeting strategy is expected
to give rise to expression of an intact PI3K-C2b protein carrying
the kinase-inactivating D1212A mutation. We previously used
this strategy to constitutively inactivate class I PI3K isoforms,
thereby uncovering non-redundant functions for these kinases
(Vanhaesebroeck et al., 2005). Mice homozygous for the PI3K-
C2b KI allele (further referred to as C2bD1212A/D1212A mice) were
born at a normal Mendelian ratio, with no impact on organismal
growth (Figure S1) or fertility. The overall histopathology of 38
tissues from these mice was investigated and, up to 20 months
of age, did not show any abnormalities (Table S1). Expression
of the mutant PI3K-C2b protein and the other, non-targeted,
PI3K isoforms (Figure 1C) was similar in C2bD1212A/D1212A and(C) PI3K isoform expression in WT and C2bD1212A/D1212A mice. Homogenates of c
immunoblotted using the indicated antibodies. Each lane represents a tissue/hepa
loaded per lane for hepatocytes and white adipose tissue, respectively.
(D) Lipid kinase activity associated with PI3K-C2b in WT and C2bD1212A/D1212A m
C2b, followed by an in vitro lipid kinase assay using PI as a substrate. n.d., not d
Cell Rewild-type (WT) mice, whereas the lipid kinase activity of PI3K-
C2b was fully lost (Figure 1D).
Improved Glucose Homeostasis and Insulin Sensitivity
in C2bD1212A/D1212A Mice
As part of a metabolic characterization of PI3K mutant mice, we
subjected C2bD1212A/D1212Amice to standardmetabolic analysis.
Six- to 8-week-old C2bD1212A/D1212A mice had unaltered blood
glucose levels under both randomly fed and fasted conditions
(Figure 2A); however, the levels of circulating insulin were
reduced under fed but not under fasted conditions (Figure 2B).
When subjected to glucose or insulin tolerance tests, overnight
fasted C2bD1212A/D1212A mice showed enhanced glucose toler-
ance (Figure 2C), due to an increased insulin hypoglycemic
response (Figure 2D). Under randomly fed conditions, WT and
C2bD1212A/D1212A mice had similar levels of circulating leptin, adi-
ponectin, triglycerides, free fatty acids, and cholesterol, with
similar food intake and energy expenditure (Table S2). Taken
together, these data reveal that PI3K-C2b negatively regulates
insulin sensitivity and glucose metabolism in vivo. Interestingly,
this metabolic phenotype was observed despite the low expres-
sion of PI3K-C2b in metabolic tissues relative to other tissues,
such as the spleen or brain (Figure 1A).
PI3K-C2b Inactivation Leads to Enhanced Insulin-
Stimulated Akt Signaling Selectively in Metabolic
Tissues
We next investigated the impact of PI3K-C2b inactivation on
insulin signaling in mice and in explanted hepatocytes. Upon
insulin stimulation, the insulin receptor (IR) at the plasma mem-
brane engages with the intracellular insulin receptor substrate
(IRS) adaptor protein that recruits several cytosolic signaling
proteins. These include the p85 subunit of the class I PI3Ks
(leading to PIP3 production and activation of Akt) and the
adaptor protein Grb2 that, through its association with the
SOS guanine nucleotide exchange factors, activates the Ras/
MAPK pathway.
Compared to WT mice, stimulation of C2bD1212A/D1212A mice
with insulin in vivo led to enhanced Akt phosphorylation in meta-
bolic tissues (liver, muscle, and white adipose tissue; Figure 3A).
Remarkably, PI3K-C2b inactivation did not lead to an increase in
insulin-induced Akt signaling in the spleen (Figure 3A), despite
high expression of PI3K-C2b in this tissue compared to meta-
bolic tissues (Figure 1A).
We next carried out a kinetic assessment of insulin signaling
in cultured primary hepatocytes isolated from WT and
C2bD1212A/D1212A mice. Also in hepatocytes, insulin-stimulated
Akt signaling was enhanced and prolonged upon PI3K-C2b inac-
tivation (Figure 3B), with no impact on MAPK signaling (Fig-
ure 3B). Interestingly, EGF- or IGF-1-induced phosphorylation
of Akt was not affected by PI3K-C2b inactivation in hepatocytes
(Figures S2A and S2B).ultured hepatocytes or white adipose tissue were resolved by SDS-PAGE and
tocyte culture derived from an individual mouse. 150 and 100 mg of protein was
ice. Brain homogenates were immunoprecipitated using an antibody to PI3K-
etected.
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Figure 2. EnhancedGlucose Tolerance and Insulin
Sensitivity in C2bD1212A/D1212A Mice
(A) Blood glucose levels under randomly fed and fasted
conditions.
(B) Plasma insulin levels under randomly fed and fasted
conditions.
(C) Glucose tolerance test after intraperitoneal injection of
2 g/kg of glucose in mice after overnight starvation.
(D) Insulin tolerance test after intraperitoneal injection of
0.75 U/kg of insulin in mice after overnight starvation.
Glucose levels are expressed relative to the levels in mice
of the same genotype before injection of insulin.
For all experiments shown, ten or more mice/genotype
were used. Data represent mean ± SEM. *p < 0.05, **p%
0.01, ***p% 0.001.PI3K-C2b Inactivation Leads to Enhanced Insulin-
Stimulated Class I PI3K Signaling
Akt is activated by PIP3 that is produced by class I PI3Ks. In line
with the enhanced activation of Akt upon PI3K-C2b inactivation
(Figure 3B), insulin-stimulated PIP3 levels were increased to a
higher extent in C2bD1212A/D1212A hepatocytes as compared to
WT cells (Figure 4A). Treatment of WT and C2bD1212A/D1212A he-
patocytes with GDC-0941, a class I PI3K-selective inhibitor,
blocked insulin-stimulated Akt activation (Figure 4B). These
data indicate that PI3K-C2b inactivation in hepatocytes leads
to an early and transient enhancement of class I PI3K activation
upon insulin stimulation, resulting in enhanced activation of Akt.
PI3K-C2b Inactivation Does Not Affect the Early Stages
of Starvation-Induced Autophagy but Induces Defects in
Endosomal Trafficking and Expansion of the APPL1
Early Endosomal Compartment
We next set out to uncover the underlying mechanism of
this temporarily enhanced insulin-induced Akt signaling, using
primary mouse hepatocytes as a cell-based model. A mass
assay to quantitate PI3P levels (Chicanne et al., 2012) revealed
a 60% reduction in the level of total PI3P in unstimulated hepa-
tocytes upon inactivation of PI3K-C2b (Figure 5A). PI3P levels
were unaffected by insulin stimulation in both WT and
C2bD1212A/D1212A hepatocytes (Figure 5A). Interestingly, PI3K-
C2b inactivation did not affect the PI3P levels in mouse embry-
onic fibroblasts or splenocytes (Figure 5A), despite the latter
expressing high levels of PI3K-C2b protein (Figure 1A).
We next assessed the subcellular distribution of PI3P in
fixed hepatocytes using a GST-2xFYVEHRS probe (Gillooly1884 Cell Reports 13, 1881–1894, December 1, 2015 ª2015 The Authorset al., 2000). In line with the PI3P quantitation
by mass assay, unstimulated C2bD1212A/D1212A
cells had a clear decrease in the number of
the PI3P-positive vesicles. However, there was
no significant difference in the size (Figure 5B;
Figure S3A) or subcellular distribution (Fig-
ure 5B) of these vesicles upon PI3K-C2b
inactivation.
Key processes in which PI3P has been impli-
cated include autophagy and endocytosis (Rai-
borg et al., 2013). WT and C2bD1212A/D1212A
hepatocytes did not show differences at theearly stage of starvation-induced autophagy, as assessed by
immunofluorescence (IF) staining for autophagic markers (LC3
and the PI3P-binding proteins WIPI-1 and WIPI-2; Figure S3B),
indicating that PI3K-C2b does not regulate the starvation-
induced autophagic PI3P pool in these cells. However, a very
mild decrease in the number of WIPI-1 punctae was observed
under non-starved conditions in C2bD1212A/D1212A hepatocytes,
compared toWT cells (Figure S3B), without any apparent impact
on LC3 punctae. This suggests that PI3K-C2bmay contribute to
a small proportion of the PI3P pool that controls basal autophagy
(i.e., the macroautophagic activity of cells in medium containing
amino acids and growth factors).
PI3P has previously been reported to be important for the con-
version of very early APPL1-positive endosomes into EEA1-pos-
itive endosomes (Zoncu et al., 2009). In accordance with the
observed reduction in PI3P in unstimulated conditions, the num-
ber, but not the overall size, of the APPL1-positive punctae was
increased in C2bD1212A/D1212A hepatocytes, compared to WT
cells (Figure 5C; Figure S3A). In addition, due to the ‘‘expansion’’
of this endosomal compartment in C2bD1212A/D1212A hepato-
cytes, the distribution of the APPL1-positive vesicles was less
restricted to the cell periphery, but instead the vesicles seemed
more dispersed toward the cytoplasm (Figure 5C, inset). Under
these conditions, EEA1-positive early endosomes and Rab7-
positive late endosomes were found to be irregularly shaped in
C2bD1212A/D1212A hepatocytes, and in the case of EEA1 endo-
somes also enlarged, whereas their numbers were unchanged
(Figure S4). Upon insulin stimulation, C2bD1212A/D1212A hepato-
cytes resulted in a further increase in the number of APPL1-pos-
itive vesicles, with a less clear impact in WT cells (Figure 5C).
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Figure 3. PI3K-C2b Inactivation Leads to Enhanced Insulin-Stimulated Akt Signaling Selectively in Metabolic Tissues
(A) Tissue homogenates, isolated from overnight starvedmice, 30min after intraperitoneal injection of 0.75 U/kg insulin or PBS, were analyzed by SDS-PAGE and
immunoblotting using the indicated antibodies. Each lane represents an individual mouse. Quantification of the signals in tissues of three to four mice/genotype is
shown. WAT, white adipose tissue.
(B) Cultured hepatocytes were starved overnight and stimulated for the indicated time points with 100 nM insulin, followed by SDS-PAGE analysis and immu-
noblotting using the indicated antibodies. Quantification of data from hepatocyte cell cultures derived from three individual mice/genotype is shown.
Data represent mean ± SEM. *p < 0.05, **p% 0.01, ***p% 0.001.Taken together, these data suggest a defect in endosomal
trafficking upon PI3K-C2b inactivation in hepatocytes, starting
at the level of the very early APPL1 compartment, which could
affect its maturation into EEA1-positive endosomes.
PI3K-C2b Inactivation Increases IR Levels and Delays IR
Trafficking
PI3P depletion in cultured mammalian cell lines (COS7, HeLa),
and the ensuing expansion of the very early APPL1 compart-
ment, has been shown to result in an accumulation of the EGF
receptor (EGFR) in this compartment (Zoncu et al., 2009) from
which endocytosed cell surface receptors can continue to signalCell Re(Platta and Stenmark, 2011). We therefore assessed the impact
of PI3K-C2b inactivation on the expression and function of the
IR, EGFR, and transferrin receptors in primary hepatocytes.
Total cell extracts of unstimulated C2bD1212A/D1212A hepato-
cytes showed increased expression of IR protein compared to
WT (Figure 6A), with no changes in the levels of IR mRNA (Fig-
ure S5) or EGFR and transferrin receptor protein levels (Fig-
ure 6A). To assess whether this increase in total IR levels was
due to higher levels of IR at the cell surface or an accumulation
in intracellular compartments, we analyzed the subcellular distri-
bution of the IR in WT and C2bD1212A/D1212A hepatocytes. When
incubated with labeled insulin at 4C, WT, and C2bD1212A/D1212Aports 13, 1881–1894, December 1, 2015 ª2015 The Authors 1885
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Figure 4. PI3K-C2b Inactivation Leads to Enhanced Insulin-Stimu-
lated Class I PI3K Signaling
(A) Hepatocytes were starved overnight and stimulated with 100 nM insulin for
the indicated time points, followed by analysis of total cellular PIP3 levels by
mass spectrometry. The mean ± SEM of four independent experiments is
shown. Hepatocyte cultures from three mice/genotype were used in three of
the experiments and three WT and two KI mice for the fourth experiment.
(B) Hepatocytes were starved overnight and treated with 500 nM GDC-0941
for 30 min before stimulation with insulin for different time points, followed by
analysis of pAkt-S473 levels. A quantification of hepatocyte cell cultures from
three independent mice/genotype is shown.
Data represent mean ± SEM. *p < 0.05, **p% 0.01, ***p% 0.001.hepatocytes showed a similar binding capacity of insulin (Fig-
ure 6B), indicative of similar levels of IR at the cell surface. Insu-
lin-induced tyrosine phosphorylation of IR was unaffected by
PI3K-C2b inactivation (Figure 6C; Figure S6). Insulin-induced
tyrosine phosphorylation of IRS1 and IRS2 was variable, and,
although a tendency for an increase was observed for IRS1 in
C2bD1212A/D1212A mice, this was not statistically significant (Fig-
ure 6C; Figure S6). Taken together, these data suggest that the
overall increase in the total levels of IR observed upon PI3K-1886 Cell Reports 13, 1881–1894, December 1, 2015 ª2015 The AutC2b inactivation (Figure 6A) is due to an increase in the pool of
intracellular IR that is not available for insulin binding at the
plasma membrane.
Despite the unchanged levels of IR at the plasma membrane,
insulin uptake at 37C was reduced by 20% in C2bD1212A/D1212A
hepatocytes, especially at the 10- and 30-min time points (Fig-
ure 6D), suggesting a delay in IR trafficking early after insulin
stimulation upon PI3K-C2b inactivation. This was also sug-
gested by subcellular fractionation of C2bD1212A/D1212A hepato-
cytes whereby the IR was found to become temporarily (i.e.,
10 min after insulin stimulation) enriched in an APPL1-positive
light microsomal cell fraction (Figure 6E). Upon insulin stimula-
tion, the IR is known to mainly recycle and not to undergo acute
degradation (Gorden et al., 1989; Knutson, 1991). Indeed, in WT
hepatocytes, IR degradation occurred over several hours upon
insulin stimulation (Figure 6F). In C2bD1212A/D1212A cells, the total
levels of IR normalized toWT levels in 6–7 hr (Figure 6F), suggest-
ing a ‘‘reset’’ of total IR levels by ligand-induced repeated endo-
cytic cycling, possibly as a consequence of a small fraction of the
IR pool being trafficked along the degradative route in each en-
docytic cycle. In contrast to the IR, PI3K-C2b inactivation did not
affect transferrin uptake (Figure S7).
Taken together, these data indicate that PI3K-C2b inactivation
does not alter IR levels at the plasma membrane but affects IR
trafficking, correlating with a temporary amplification of insulin-
stimulated class I PI3K/Akt signaling.
C2bD1212A/D1212A Mice Are Protected against High-Fat-
Diet-Induced Steatosis
To investigate the role of PI3K-C2b in a pathophysiological
context, WT and C2bD1212A/D1212A mice were subjected to a
high-fat diet for 16 weeks. Whereas PI3K-C2b inactivation did
not affect body-weight increase (Figure 7A), C2bD1212A/D1212A
mice showed a significant reduction in liver weight gain (Fig-
ure 7B), a significant protection against liver steatosis (Figure 7C)
as well as reduced levels of neutral lipids (as documented by oil
red O staining) and triglycerides in the liver (Figure 7D).
C2bD1212A/D1212A mice were also less insulin-resistant than WT
mice (Figure 7E). Taken together, our data highlight an important
role of PI3K-C2b in insulin signaling and glucose metabolism,
especially in the liver.
DISCUSSION
A New Model for Studying the In Vivo Role of the Kinase
Activity of PI3K-C2b
No selective class II PI3K inhibitors are available. In order to
assess the role of the kinase activity of the PI3K-C2b isoform
of class II PI3Ks, we have created a mouse model in which
this PI3K isoform has been rendered inactive by introduction
of a germline KI mutation in the conserved DFG motif of the
ATP-binding site. We previously used this strategy to uncover
biological roles of the class I PI3Ks (Ali et al., 2004; Foukas
et al., 2006; Graupera et al., 2008; Guillermet-Guibert et al.,
2008; Okkenhaug et al., 2002). In contrast to PI3K gene deletion,
such a KI strategy inactivates the PI3K in an inhibitor-like fashion,
preserves the molecular balance of the expression of PI3K iso-
forms, minimizes compensatory effects, and, therefore, allowshors
MEFshepatocytesA
insulin: - +
P
I3
P
 (%
 o
f P
I3
P
 in
 
un
st
im
ul
at
ed
 W
T 
ce
lls
)
splenocytes
WT
C2βD1212A/D1212A 
no insulin no insulin
P
I3
P
(%
 o
f P
I3
P
 in
 W
T 
ce
lls
)
P
I3
P
(%
 o
f P
I3
P
 in
 W
T 
ce
lls
)
* *
WTB
WT
C2βD1212A/D1212A 
**
ve
si
cl
e 
nu
m
be
r/c
el
l
no
 in
su
lin
WT C2βD1212A/D1212A 
PI3P (GST-2XFYVEHrs)
APPL1
ve
si
cl
e 
nu
m
be
r/c
el
l
C
WT
C2βD1212A/D1212A 
no
 in
su
lin
WT C2βD1212A/D1212A 
20μm
20μm
+ 
in
su
lin
** **
insulin: +-
*
WT C2βD1212A/D1212A 
WT C2βD1212A/D1212A 
Figure 5. PI3K-C2b Inactivation Induces Endosomal Trafficking Defects and Expansion of the Very Early APPL1 Endosomal Compartment
(A) Analysis of total cellular PI3P levels in different cell types/tissues. Hepatocytes and MEFs were starved overnight, and hepatocytes were stimulated with or
without insulin (100nM) for 10 min. Splenocytes were collected from mice after overnight starvation. Cell cultures from five mice/genotype were used for all
tissues, except for MEF (three WT/six C2bD1212A/D1212A).
(B) Analysis of endogenous PI3P in fixed overnight starved hepatocytes by staining using a GST-2xFYVEHRS probe.
(C) Analysis of APPL1 staining in overnight starved hepatocytes stimulated with or without insulin (100nM) for 10 min.
(B and C) DAPI-stained nuclei are shown in blue. The inset shows a higher magnification (3003) of FYVE- and APPL1-positive vesicles. Quantification using
Metamorph software was performed on three to five independent hepatocyte cell cultures/genotype. Scale bar, 20 mm.
Data represent mean ± SEM. *p < 0.05, **p% 0.01, ***p% 0.001.
Cell Reports 13, 1881–1894, December 1, 2015 ª2015 The Authors 1887
Tf
R
/v
in
cu
lin
IR
vinculin
TfR
tubulin
EGFR
A
IR
/v
in
cu
lin
E
G
FR
/v
in
cu
lin
*
WT
C2βD1212A/D1212A 
in
su
lin
 u
pt
ak
e
(m
ea
n 
flu
or
es
ce
nc
e 
in
te
ns
ity
)
D
0 10 60insulin (min):
*
*
5 30
WT
C2βD1212A/D1212A 
insulin (min): 60100 60100
WT C2βD1212A/D1212A 
*
IR
 q
ua
nt
ifi
ca
tio
n
(%
 o
f t
he
 n
on
-in
su
lin
-s
tim
ul
at
ed
)
Light microsomal fraction (LM)
Plasma membrane fraction  (PM)    
IR
APPL1
LM PMLM PMLM PM LM PMLM PMLM PM
E WT C2βD1212A/D1212A 
insulin (min): 100 10060 60
* *
B
WT
C2βD1212A/D1212A 
in
su
lin
 b
in
di
ng
(m
ea
n 
flu
or
es
ce
nc
e 
in
te
ns
ity
)
F
IR
vinculin
insulin (h): 0 2 4 6 12 24
WT C2βD1212A/D1212A 
0 2 4 6 12 24
insulin stimulation (h)
* WTC2βD1212A/D1212A 
fo
ld
 in
du
ct
io
n 
(o
ve
r W
T 
no
n -
in
su
lin
- s
tim
ul
at
ed
)
C
fo
ld
 in
du
ct
io
n 
(o
ve
r n
on
-in
su
lin
-s
tim
ul
at
ed
)
fo
ld
 in
du
ct
io
n 
(o
ve
r n
on
-in
su
lin
-s
tim
ul
at
ed
)
fo
ld
 in
du
ct
io
n 
(o
ve
r n
on
-in
su
lin
-s
tim
ul
at
ed
)
0 10insulin (min): 5
IP: IR
WB: p-Tyr
WT
C2βD1212A/D1212A 
IP: IRS2
WB: p-Tyr
0 10insulin (min): 5
0 10insulin (min): 5
IP: IRS1
WB: p-Tyr
(legend on next page)
1888 Cell Reports 13, 1881–1894, December 1, 2015 ª2015 The Authors
assessment of the role of the catalytic activity rather than
possible scaffolding functions of the targeted PI3K.
PI3K-C2b Inactivation Increases Insulin Sensitivity and
Glucose Metabolism
Our study uncovered that kinase inactivation of PI3K-C2b in
mice enhances insulin sensitivity and protects against high-fat-
diet-induced hepatic steatosis. These findings were unex-
pected, for several reasons. First, previous studies in cell lines
had mainly implicated PI3K-C2a, and not PI3K-C2b, in insulin
signaling (Brown et al., 1999; Falasca et al., 2007; Leibiger
et al., 2010; Soos et al., 2001; Ursø et al., 1999) and insulin secre-
tion (Dominguez et al., 2011), although in most of these studies,
the role of PI3K-C2b was not assessed. Second, it was remark-
able to observe that inactivation of a kinase leads to improved
insulin signaling and metabolic sensitization. Last, and still
unexplained, is the apparent exclusive action of PI3K-C2bdown-
stream of insulin, and its restriction to Akt signaling and meta-
bolic tissues (discussed in more detail below).
Although we focused our experiments on hepatocytes, it is
likely that the adipose tissue and muscle are also functionally
involved in the global metabolic improvement seen in PI3K-
C2b KI mice, as we also observed clearly enhanced insulin-
induced Akt activation in these tissues. Based on the notion
that insulin and activation of Akt are known to induce lipid stor-
age in the liver (Leavens and Birnbaum, 2011), sustained hepatic
Akt activation could be expected to lead to an increase in stea-
tosis. This is also supported by observations in transgenic mice
that express membrane-bound (and therefore constitutively
active) Akt in the liver (Ono et al., 2003) or in mice with liver-spe-
cific deletion of PTEN (Horie et al., 2004), which also show
enhanced steatosis. While it is challenging to link short-term
signaling (minutes to hours) to long-term biological effects
(4 months in the case of high-fat diet), it is important to mention
that, in contrast to the constitutive over-activation of Akt in the
mutant mice mentioned above, C2bD1212A/D1212A mice only
display a transient over-activation of Akt upon insulin stimulation.
Moreover, it is very likely that the systemic enhancement in insu-
lin sensitivity, with increased Akt activity in muscle and adipose
tissue in addition to the liver, leads to an overall improved meta-
bolism of C2bD1212A/D1212A mice, which reduces the develop-
ment of hepatic steatosis as a consequence.Figure 6. Impact of PI3K-C2b Inactivation on IR Levels and Trafficking
(A) Expression levels of IR, EGF, and transferrin receptor in total cell extracts. Ho
using indicated antibodies. Quantification of three to five independent hepatocyt
(B) Insulin binding capacity of hepatocytes. Quantification of three independent
(C) Cultured hepatocytes were serum-starved overnight and stimulated for the in
indicated antibodies. The immune complexes were analyzed by western blot an
cation of western blots from four to five independent experiments, shown in Figu
average of experiments a–d); time point 5 min: averages of experiments b–e; tim
(D) Insulin uptake in hepatocytes. Quantification of five independent hepatocyte
(E) Distribution of IR and APPL1 in subcellular fractions of hepatocytes. Hepatoc
points, followed fractionation of lysates in light microsome (LM) and plasmamemb
immunoblotting with antibodies to the indicated proteins. A representative experim
fraction in WT and C2bD1212A/D1212A cells stimulated for 10 min with insulin. Thre
(F) Insulin-stimulated IR degradation in hepatocytes. Cells were starved overnigh
analysis and immunoblotting using antibodies to IR. Three independent hepatoc
Data represent mean ± SEM. *p < 0.05, **p% 0.01, ***p% 0.001.
Cell ReTogether with the observation that no abnormalities were
observed in an in-depth histopathological analysis of adult
C2bD1212A/D1212A mice, our data identify PI3K-C2b as a potential
drug target for insulin sensitization in the treatment of insulin
resistance in type 2 diabetes or non-alcoholic fatty liver disease.
PI3K-C2b Is a Major Endosomal Producer of Basal PI3P
in Hepatocytes
One previous study has implicated PI3K-C2b in PI3P produc-
tion, namely, in the PI3P synthesis induced by lysophosphatidic
acid in HeLa and SKOV-3 cell lines (Maffucci et al., 2005). Our
study shows that PI3K-C2b is required for a large fraction
(60%) of the basal PI3P in hepatocytes and therefore demon-
strates that class II PI3Ks can significantly contribute to PI3P
pools in vivo in the liver. Interestingly, the reduction in PI3P
upon PI3K-C2b inactivation selectively impacted on endosomal
trafficking but did not affect the formation of starvation-induced
early autophagic vacuoles in these cells, indicating that PI3K-
C2b mainly controls the endosomal PI3P pool in hepatocytes.
It is possible that vps34 or class II PI3K isoforms other than
PI3K-C2b (Devereaux et al., 2013) generate the autophagic
PI3P pool in the liver.
PI3K-C2b Inactivation Results in an ‘‘APPL1 Expansion
Signature’’
IF analysis of intracellular vesicles revealed that PI3K-C2b inac-
tivation led to an expansion of the very early APPL1-positive
endosomal compartment in hepatocytes, under basal and
insulin-stimulated conditions. We show in this study that
PI3K-C2b is linked to the regulation of intracellular vesicular
trafficking.
APPL1 is a scaffolding protein with multiple functional do-
mains, including a Bin1/amphiphysin/rvs167 (BAR) domain, a
PH domain, a phosphotyrosine binding (PTB) domain, and a
CC motif (Deepa and Dong, 2009). APPL1 interacts with various
receptors (such as the IR, TrkA, and the adiponectin receptor),
signaling and scaffolding proteins (including Akt, IRS, and the
OCRL inositol polyphosphate 5-phosphatase), and vesicular
trafficking proteins (such as GTP-bound Rab5) (Deepa and
Dong, 2009; Ryu et al., 2014). Our findings are in line with
a cell-based study that highlighted a critical role for PI3P in
the maturation of the APPL1-positive very early endosomes toin Hepatocytes
mogenates of hepatocytes were analyzed by SDS-PAGE and immunoblotting
e cultures/genotype is shown.
hepatocyte cultures/genotype is shown.
dicated times with 100 nM insulin, followed by immunoprecipitation using the
d probed with the indicated antibodies. The bar charts represent the quantifi-
re S6 as follows: time point 0: averages of experiments a–e (apart from IRS1,
e point 10 min: averages of experiments a–c.
cultures/genotype is shown.
ytes were starved overnight and stimulated with insulin for the indicated time
rane (PM) fractions by ultracentrifugation, followed by SDS-PAGE analysis and
ent is shown. The star indicates the different levels of IR in the APPL1-positive
e independent hepatocyte cell cultures/genotype were used.
t, stimulated with insulin for the indicated time points, followed by SDS-PAGE
yte cell cultures/genotype were used.
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Figure 7. C2bD1212A/D1212A Mice Are Protected against High-Fat-Diet-Induced Steatosis
(A) Body weight of mice during 16 weeks of high-fat diet.
(B) Liver weight after 16 weeks of high-fat diet. Five to ten livers/genotype were used of mice on a normal (control) or high-fat diet.
(C) Liver histology. H&E staining of liver sections of mice after 16 weeks of high-fat diet. Quantification of vacuolization of seven livers/genotype is shown on the
right. a.u., arbitrary units. Scale bar, 50 mm.
(D) Oil red O staining and liver triglyceride levels. Oil red O staining of liver sections after 16 weeks of normal or high-fat diet. Tenmice/genotype. Scale bar, 50 mm.
(E) Insulin tolerance test after intraperitoneal injection of 0.75 U/kg of insulin in overnight starved mice. Ten mice/genotype.
(F) Model of the role of PI3K-C2b in PI3P production in hepatocytes and its impact on IR trafficking through endosomal compartments. In WT cells, PI3K-C2b
generates a large fraction of the PI3P that controls the maturation of the very early APPL1-positive endosomes into early EEA1-positive endosomes. In WT mice,
this attenuates IR signaling by enabling the transit of IR through endosomal compartments, either toward recycling or degradation. Inactivation of PI3K-C2b leads
to a decrease in endosomal PI3P, which could delay the maturation of the very early APPL1-positive endosomes into early EEA1-positive endosomes. This leads
to an accumulation of APPL1-positive endosomes and temporarily affects IR trafficking, correlating with an increased and more sustained Akt signaling in
metabolic tissues. This increase in Akt signaling enhances insulin sensitivity and glucose metabolism in cells and mice with inactive PI3K-C2b.
Data represent mean ± SEM. *p < 0.05, **p% 0.01, ***p% 0.001.EEA1-positive early endosomes (Zoncu et al., 2009). These au-
thors showed that PI3P depletion in the Rab5-positive compart-
ment (by introduction of PI3P-specific phosphatases) led to an1890 Cell Reports 13, 1881–1894, December 1, 2015 ª2015 The Autaccumulation of the EGFR in an expanded very early APPL1-
positive endosomal compartment upon EGF stimulation, result-
ing in enhanced downstream signaling (Zoncu et al., 2009). Ourhors
study uncovers a similar APPL1-based mechanism for IR traf-
ficking, correlating with enhanced insulin-stimulated Akt activa-
tion. Further support for a role for APPL1 in insulin action comes
from observations made by APPL1 KO/overexpression in mice.
For example, APPL1 KO mice show the opposite metabolic
phenotype to C2bD1212A/D1212A mice, being insulin-resistant
and glucose-intolerant with decreased insulin-stimulated Akt
signaling in the liver, muscle, and adipose tissue (Ryu et al.,
2014). Conversely, APPL1 overexpression in the liver increases
Akt activation and alleviates insulin resistance in obese mice
(Cheng et al., 2009).
PI3K-C2b Inactivation Enhances Insulin Signaling in
Metabolic Tissues
Under basal conditions, C2bD1212A/D1212A hepatocytes had sub-
stantially lower levels of total cellular PI3P than WT cells. Insulin
stimulation of these cells did not alter PI3P levels in either geno-
type but did increase PIP3 levels, as expected. Interestingly, in-
sulin stimulation led to a higher PIP3 increase in C2b
D1212A/D1212A
hepatocytes compared to WT cells.
These data are consistent with a model (Figure 7F) whereby,
in hepatocytes, PI3K-C2b is responsible for the constitutive
production of a large fraction of the PI3P required for the basal
endosomal flux. Under basal conditions, C2bD1212A/D1212A hepa-
tocytes had an 2-fold increase in overall IR levels over WT
cells, without higher IR expression at the cell surface, pointing
to the existence of an intracellular pool of IR. At present, the
exact subcellular location of this IR pool is unknown. Given
that the APPL1-positive compartment is expanded, it is possible
that the IR is stuck as a consequence of a ‘‘traffic jam’’ in its en-
docytic flux.
Upon insulin stimulation, there was no difference in tyrosine
phosphorylation of the IR, in line with unaltered IR levels at the
cell surface. However, as insulin-mediated Akt signaling was
temporarily enhanced upon PI3K-C2b inactivation, it is possible
that the ligand-bound IR signals longer as a result of its slower
endocytosis due to the ‘‘traffic jam’’ in the APPL1 compartment.
A similar phenomenon was previously shown for the EGFR and
its downstream signaling upon expansion of the APPL1
compartment due to PI3P reduction (Zoncu et al., 2009). Upon
prolonged (6–7 hr) exposure to insulin, the higher overall IR
levels in C2bD1212A/D1212A hepatocytes were found to return to
that seen in WT cells, possibly due to insulin-induced repeated
endocytic cycling whereby a small fraction of the activated IR
pool is trafficked along the degradative route in each endocytic
cycle.
Supportive of our model that IR traffic is delayed in the APPL1
compartment is the recent report showing that APPL1 can bind
both IR and IRS and facilitate the insulin-stimulated interaction
between IR and IRS (Ryu et al., 2014). The capacity of IR/IRS/
Akt/APPL1 to dynamically interact, in a subcellular compartment
controlled by PI3P, is likely to be key in explaining the selective
metabolic impact of PI3K-C2b inactivation.
Unfortunately, we were not able to visualize endogenous IR,
PIP3, or phospho-Akt by IF using an extensive range of home-
made or commercially available antibodies. IF analyses using
fluorescently labeled insulin on primary hepatocytes, both on
fixed cells or by live imaging, were also not successful. We there-Cell Refore do not know the exact subcellular location of increased PIP3
production and Akt activation upon PI3K-C2b inactivation.
Selective Role of PI3K-C2b in Insulin-Stimulated Akt
Activation in Metabolic Tissues
One of the most surprising findings of our work is the apparent
exclusive action of PI3K-C2b downstream of insulin, and its re-
striction to Akt signaling and metabolic tissues. Our data clearly
show that a reduction in PI3P, as a consequence of PI3K-C2b
inactivation, and the ensuing block in endosomal traffic en-
hances cell signaling in a very specificmanner. At the organismal
level, PI3K-C2b inactivation induced an increase in insulin-stim-
ulated Akt signaling specifically in insulin target tissues (liver,
muscle, and adipose tissue) but not in the spleen where PI3K-
C2b is expressed highly. PI3K-C2b inactivation did also not
affect the basal levels of PI3P in splenocytes or MEFs. Further
studies conducted on hepatocytes showed additional specificity
of PI3K-C2b action. First, at the receptor level, PI3K-C2b inacti-
vation led to increased IR protein expression in these cells,
without altering the levels of the receptors for EGF or transferrin
andmodulated the intracellular trafficking of the IR but not that of
the transferrin receptor. Second, at the ligand level, PI3K-C2b
inactivation increased insulin-induced Akt signaling in hepato-
cytes, without altering EGF- or IGF-mediated Akt signaling.
Last, but not least, at the downstream signaling level, PI3K-
C2b inactivation in hepatocytes led to an increased insulin-stim-
ulated Akt activation without affecting MAPK signaling.
At present, we do not have a clear explanation for these obser-
vations. The absolute expression levels of the PI3K-C2b protein
in different tissues are unlikely to be key in this phenomenon,
given that PI3K-C2b expression is high in the spleen compared
to liver. PI3P turnover in different tissues may depend on tis-
sue-specific activities of the PI3Ks and other PI kinases but
also of lipid phosphatases. It is also possible that such specificity
could be provided by the scaffolding properties of APPL1, allow-
ing this protein to interact with tissue- and receptor-specific
binding partners, creating tissue-/ligand-/signaling-selective
protein hubs. It is of interest to note that, despite the broad tissue
distribution of APPL1, numerous studies have described APPL1
as an important player specifically in metabolic tissues and in
particular in insulin signaling (Cheng et al., 2014). In line with
our observations, other studies have documented that alter-
ations in APPL1 expression can differentially affect signaling de-
pending on the stimulus. For example, APPL1 KO in MEFs was
found to reduce Akt activation induced by Hepatocyte Growth
Factor, but not by EGF, insulin, or serum (Tan et al., 2010). Like-
wise, APPL1 knockdown in zebrafish led to a decrease in growth
factor-induced Akt signaling with no impact on MAPK (Schenck
et al., 2008). These data suggest that APPL1 endosomes can
serve as signaling platforms for selective recruitment and activa-
tion of signaling components.
Conclusions
Taken together, our study reports on the creation of the class II
PI3K knockin mice to model systemic PI3K-C2b kinase inactiva-
tion and identifies this isoform of PI3K as a drug target for the
treatment of insulin resistance in type 2 diabetes or non-alco-
holic fatty liver diseases.ports 13, 1881–1894, December 1, 2015 ª2015 The Authors 1891
EXPERIMENTAL PROCEDURES
Mice
All experiments were performed on 6- to 12-week-old male C57BL/6J mice,
unless otherwise specified. Mice were kept on standard chow diet (20% pro-
tein, 75% carbohydrate, 5% fat) on a 12-hr light-dark cycle (lights on at 7 a.m.)
with free access to water in individually ventilated cages and cared for accord-
ing to United KingdomAnimals (Scientific Procedures) Act (1986). For high-fat-
diet experiments, mice were maintained on diet 824053 from Special Diet
Services (20% protein, 35% carbohydrate, and 45% fat) for 16 weeks.
Creation of C2bD1212A Mice and PCR Genotyping
Mouse gene targeting was performed by Artemis in C57BL/6NT embryonic
stem cells. Mice were backcrossed on the C57BL/6J strain (Charles River
Laboratories) for greater than ten generations, and mice used for experiments
were on mixed C57BL/6J 3 C57BL/6NT background, with WT littermates
used as controls. The sequences of the primers used for genotyping are as
follows: forward primer (a in Figure 1B): 1614-29 KI: CACTGCAGGAAGT
GTGAAGC; antisense primer (b in Figure 1B): 1614-30 KI: GTGGACA
GAAAGGCTGATGC, with expected fragments of 235 (WT) and 398 (KI) bp.
PCR conditions were as follows: 95C for 5 min, 34 cycles of (95C 30 s,
65C 30 s, 72C 1 min) and 72C for 10 min. The presence of the D1212A mu-
tation was verified by sequencing of a PCR fragment generated using forward
primer 1743-25 ivm: GCTTTGGTATATGATGAAGG (c in Figure 1B) and anti-
sense primer 1743-26 ivm: GTCTTCTGGTCTCCAGAAGC (d in Figure 1B)
using the PCR conditions described above. PCRs were performed using Tita-
nium Taq polymerase (Clontech) on a ThermalCycler (MJ Research).
Hepatocyte and Mouse Embryonic Fibroblast Isolation and Culture
Primary mouse hepatocytes were isolated from 8- to 12-week-old mice as
described, with minor changes (Guidotti et al., 2003). Briefly, primary hepato-
cytes were isolated by a two-step perfusion protocol using collagenase I
(Sigma) and seeded on collagen-coated plates in complete medium (William’s
E GlutaMAXmedium containing 0.1%BSA, 1% penicillin/streptomycin, 25 nM
dexamethasone [Sigma], and 100 nM insulin) in the presence of 10% (v/v) fetal
bovine serum (FBS). After 4 hr incubation at 37C to allow cell adhesion, the
medium was replaced either by starvation medium (complete medium without
insulin) or complete medium (for autophagy studies), and cells were further
incubated at 37C overnight.
For signaling studies, fluorescence-activated cell sorting (FACS) analysis,
immunofluorescence, lipid analysis, and cell fractionation, culture medium
was removed and replaced by fresh starvation medium containing insulin
(100 nM), EGF (200 nM), or IGF-1 (3.9 nM) for the indicated times. In some ex-
periments, GDC-0941 (500 nM) was added at 30 min before cell stimulation.
For autophagy studies, complete medium was removed and cultures were
washed twice with amino-acid- and serum-free medium (EBSS; Invitrogen),
and cells were maintained in EBSS for 30 min. Control, non-starved cells
were washed in complete medium instead of EBBS.
Mouse embryonic fibroblasts (MEFs) were isolated from intercrosses of
mice heterozygous for the PI3K-C2bD1212A allele as described (Foukas et al.,
2006).
Antibodies and Reagents
All antibodies were against mouse proteins as follows: APPL1, EEA1, Rab7,
GST, pAkt-S473, pAkt-T308 Akt, p42/44 pMAPK-T202/pY204, Akt, p110a, in-
sulin receptor, vps34 (Cell Signaling Technology); PI3K-C2a, PI3K-C2b (BD
Biosciences); p110b, ptyr99 (Santa Cruz Biotechnology); vinculin, a-tubulin,
EGFR (Sigma); transferrin receptor (Abcam); and LC3 (2G6; Nanotools). Anti-
bodies to WIPI-1 and WIPI-2 were kindly provided by Sharon Tooze (London
Research Institute). In-house-made antibodies to IRS1 and IRS2 were pro-
vided by Dominic Withers (Imperial College London). Fluorescein isothiocya-
nate (FITC)-insulin (bovine) was from Sigma, and FITC-transferrin (human)
was from Molecular Probes. Unless otherwise mentioned, PBS (Sigma) was
Ca2+ and Mg2+ free. All culture media for primary cell culture were from Invitro-
gen. A plasmid expressing GST-2xFYVEHRS (Gillooly et al., 2000) was kindly
provided by Harald Stenmark, Norway. Recombinant GST protein was purified
from E. coli BL21 (DE3) cells according to the manufacturer’s instructions. All1892 Cell Reports 13, 1881–1894, December 1, 2015 ª2015 The Autbuffers used during purification of the GST-fusion steps were EDTA free, and
the recombinant protein was dialyzed against HEPES buffer (pH 7.4) contain-
ing 10 mM ZnCl2. Agonists used were insulin (human [Actrapid] and bovine
[Sigma] for in vivo and in vitro experiments, respectively), EGF (human; Pepro-
Tech), or IGF-1 (human; PeproTech). GDC-0941 was from Axon-Medchem.
Statistical Analysis
All data are shown as mean ± SEM. Data sets were compared for statistical
significance using a two-tailed Student’s t test. All statistical analyses were
generated using Excel software and statistical significance indicated as *p <
0.05, **p% 0.01, ***p% 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
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